References
Nightingale SD, et al. N Engl J Med 329: 828–833, 1993
Kemper CA, et al. Ann Intern Med 116: 466–472, 1992
Barradell LB, et al. Drugs 46: 289–312, 1993
Horsburgh CR Jr. N Engl J Med 324: 1332–1338, 1991
Rathbun RC, et al. Clin Pharm 10: 280–291, 1991
Nightingale SD, et al. J Infect Dis 165: 1082–1085, 1992
Peters DH, Clissold SP. Drugs 44: 117–164, 1992
Chaisson RE, et al. Abstract 891. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Anaheim, California, 11–14 October, 1992
Dautzenberg B, et al. Am Rev Resp Dis 144: 564–569, 1991
Prokocimer P, et al. Abstract 634. 30th Intersciences Conference on Antimicrobial Agents and Chemotherapy, 1991
Ruf B, et al. Infection 20: 267–272, 1992
Wu AW, et al. Abstract PoB3550. VIII International Conference of AIDS/III STD World Congress, Amsterdam, The Netherlands, 19–24 July, 1992
Guay DRP, et al. Drug Saf 8: 350–364, 1993
Harb GE, Jacobson MA. Drug Saf 9: 1–8, 1993
Jorup-Rönström C, et al. J Infect 26: 67–70, 1993
Horsburgh CR, et al. Am Rev Resp Dis 144: 557–559, 1991
Rights and permissions
About this article
Cite this article
Clarithromycin improves prospects for treatment of disseminated MAC infection. Drugs Ther. Perspect 3, 1–4 (1994). https://doi.org/10.2165/00042310-199403010-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199403010-00001